title: Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure.
abstract: BACKGROUND
  Adrenomedullin, a potent endogenous vasodilating and natriuretic peptide, may play an important role in the pathophysiology of chronic heart failure. Plasma levels of immunoreactive adrenomedullin were examined for prediction of prognosis in chronic heart failure.
  
  
  RESULTS
  Plasma levels of immunoreactive-ADM (ir-ADM) were measured by radioimmunoassay in 117 chronic heart failure patients with idiopathic or ischaemic cardiomyopathy (mean ejection fraction: 28 +/- 10%, in the NYHA functional class I/II/III/IV:8/73/29/7, and treated with ACE inhibitors and diuretics. Plasma levels of immunoreactive adrenomedullin were significantly increased in chronic heart failure patients by comparison to controls (618 +/- 293 pg x ml(-1) vs 480 +/- 135 pg x ml(-1), P=0.01). During the follow-up period (237 +/- 137 days) 14 cardiovascular deaths and four urgent cardiac transplantations occurred. In the univariate Cox model, immunoreactive adrenomedullin plasma levels were related to prognosis (P=0.004). A multivariate analysis including heart rate, systolic blood pressure, NYHA class, left ventricular ejection fraction, left ventricular echocardiographic end-diastolic diameter, plasma levels of immunoreactive adrenomedullin, endothelin-1, norepinephrine and atrial natriuretic peptide was performed: plasma levels of immunoreactive adrenomedullin (P=0.03), of endothelin-1 (P=0.0001), and systolic blood pressure (P=0.003) were significantly associated with outcome.
  
  
  CONCLUSIONS
  Our results suggest that elevated plasma levels of immunoreactive adrenomedullin are an independent predictor of prognosis in predominantly mild to moderate chronic heart failure treated by conventional therapy and provide additional prognostic information.
authors.affiliation: Department of Cardiology, Pitié-Salpêtrière Hospital, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Pousset
authors.forename: F
authors.initials: F
authors.lastname: Masson
authors.forename: O
authors.initials: O
authors.lastname: Chavirovskaia
authors.forename: R
authors.initials: R
authors.lastname: Isnard
authors.forename: A
authors.initials: A
authors.lastname: Carayon
authors.forename: J L
authors.initials: JL
authors.lastname: Golmard
authors.forename: P
authors.initials: P
authors.lastname: Lechat
authors.forename: D
authors.initials: D
authors.lastname: Thomas
authors.forename: M
authors.initials: M
authors.lastname: Komajda
mesh_terms: D053607:Adrenomedullin; D000328:Adult; D000368:Aged; D002303:Cardiac Output, Low / Q000097:blood / Q000503:physiopathology*; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood*; D011379:Prognosis; D011863:Radioimmunoassay
chemical_list: D010455:Peptides; D053607:Adrenomedullin